
Find a Doctor

Deana M. Gazzola, MD, is the medical director of the Epilepsy Monitoring Unit, a neurologist in the Epilepsy Program, and a professor in the Department of Neurology at Barrow Neurological Institute. She is board certified in neurology, epilepsy, and clinical neurophysiology by the American Board of Psychiatry and Neurology.
Dr. Gazzola’s expertise is in the diagnosis and treatment of epilepsy and other seizure disorders. She is a member of the American Academy of Neurology, the American Clinical Neurophysiology Society, and the American Epilepsy Society.
Dr. Gazzola earned her medical degree from the University of Pennsylvania in Philadelphia. She completed her neurology residency and a clinical neurophysiology fellowship at the Hospital of the University of Pennsylvania. She also completed a research neurophysiology fellowship at New York University School of Medicine in New York City.
Dr. Gazzola’s research interests focus on quality improvement projects that are both clinical and education based.
- Research Fellowship, New York University School of Medicine, Neurophysiology, 2007-2008
- Clinical Neurophysiology Fellowship, Hospital of the University of Pennsylvania, 2006-2007
- Residency, Hospital of the University of Pennsylvania, Neurology, 2003-2006
- Internship, Hospital of the University of Pennsylvania, Internal Medicine, 2002-2003
- MD, University of Pennsylvania, 2002
- AB, Princeton University, Molecular Biology, 1998
- American Academy of Neurology
- Fellow, American Clinical Neurophysiology Society
- American Epilepsy Society
- Rising Star, Super Doctors – New York, 2013-2015
- Dreifuss National EpiFellows Award for Clinical Research, American Academy of Neurology, 2007
- Eric Corey Raps Memorial Prize, University of Pennsylvania School of Medicine, Department of Neurology, 2002
- Medical Student Prize for Excellence in Neurology, American Academy of Neurology, 2002
A novel RGD-independent fibronectin assembly pathway initiated by alpha4beta1 integrin binding to the alternatively spliced V region.
Date: 04/2000
Authors: J L Sechler, A M Cumiskey, D M Gazzola, J E Schwarzbauer
- English

- (602) 406-6262
- Fax: (602) 406-6261

Deana M. Gazzola, MD, is the medical director of the Epilepsy Monitoring Unit, a neurologist in the Epilepsy Program, and a professor in the Department of Neurology at Barrow Neurological Institute. She is board certified in neurology, epilepsy, and clinical neurophysiology by the American Board of Psychiatry and Neurology.
Dr. Gazzola’s expertise is in the diagnosis and treatment of epilepsy and other seizure disorders. She is a member of the American Academy of Neurology, the American Clinical Neurophysiology Society, and the American Epilepsy Society.
Dr. Gazzola earned her medical degree from the University of Pennsylvania in Philadelphia. She completed her neurology residency and a clinical neurophysiology fellowship at the Hospital of the University of Pennsylvania. She also completed a research neurophysiology fellowship at New York University School of Medicine in New York City.
Dr. Gazzola’s research interests focus on quality improvement projects that are both clinical and education based.

- (602) 406-6262
- Fax: (602) 406-6261
- Research Fellowship, New York University School of Medicine, Neurophysiology, 2007-2008
- Clinical Neurophysiology Fellowship, Hospital of the University of Pennsylvania, 2006-2007
- Residency, Hospital of the University of Pennsylvania, Neurology, 2003-2006
- Internship, Hospital of the University of Pennsylvania, Internal Medicine, 2002-2003
- MD, University of Pennsylvania, 2002
- AB, Princeton University, Molecular Biology, 1998
- American Academy of Neurology
- Fellow, American Clinical Neurophysiology Society
- American Epilepsy Society
- Rising Star, Super Doctors – New York, 2013-2015
- Dreifuss National EpiFellows Award for Clinical Research, American Academy of Neurology, 2007
- Eric Corey Raps Memorial Prize, University of Pennsylvania School of Medicine, Department of Neurology, 2002
- Medical Student Prize for Excellence in Neurology, American Academy of Neurology, 2002
A novel RGD-independent fibronectin assembly pathway initiated by alpha4beta1 integrin binding to the alternatively spliced V region.
Date: 04/2000
Authors: J L Sechler, A M Cumiskey, D M Gazzola, J E Schwarzbauer
- English